Study title: AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. IN C/Ecija, 101,28230 Las Rozas, Spain. SO Anales Espanoles de Pediatria {AN-ESP-PEDIATR}, 1993, Vol/Iss/Pg. 38 /6 (509-515), ISSN: 0302-4342. YR 1993.AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. I...
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Endocrine System Diseases [C19] | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CYPROHEPTADINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |